People: AcelRx Pharmaceuticals Inc (ACRX.O)
18 Dec 2013
Mr. David H. Chung has been appointed as Chief Commercial Officer of AcelRx Pharmaceuticals, Inc., with effect from September 2, 2013. While at Conceptus, Mr. Chung oversaw the strategic and day-to-day leadership of a global sales and marketing organization that consisted of 144 people. Prior to Conceptus, Mr. Chung served as president and CEO of Mitralis, an early stage transcatheter mitral valve repair company. Prior to Mitralis, Mr. Chung held the position of global vice president, commercial operations, Heart Valve Therapy at Edwards Lifesciences/Baxter Healthcare, the culmination of 15 years at the company in various commercial roles of increasing responsibility. Prior to Baxter, Mr. Chung began his career at Pfizer in a sales capacity in both the medical device and pharmaceutical sales arenas. Mr. Chung earned a B.S. in general engineering from the United States Military Academy, West Point, N.Y.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|